Table 1. Characteristics of group A and group B.
| Variable | Group A (n = 13) | Group B (n = 13) | P of difference |
|---|---|---|---|
| Type of tumor | 1 | ||
| HCC | 12 | 13 | |
| ICC | 1 | 0 | |
| Gender | 1 | ||
| Male | 9 | 9 | |
| Female | 4 | 4 | |
| Pre-operative radiation | 1 | ||
| No | 12 | 13 | |
| Yes | 1 | 0 | |
| Liver cirrhosis | 0.48 | ||
| No | 2 | 0 | |
| Yes | 11 | 13 | |
| HBsAg | 0.593 | ||
| Negative | 2 | 1 | |
| Positive | 10 | 12 | |
| HCV-IgG | 1 | ||
| Negative | 10 | 11 | |
| Positive | 1 | 0 | |
| Pre-operative EHM | 1 | ||
| No | 11 | 10 | |
| Yes | 2 | 3 | |
| Pre-operative LNM | 1 | ||
| No | 11 | 12 | |
| Yes | 2 | 1 | |
| Location of HVTT | 0.817 | ||
| Left HV | 2 | 4 | |
| Middle HV | 5 | 4 | |
| Right HV | 4 | 5 | |
| Accessory HV | 1 | 0 | |
| Left + middle HV | 1 | 0 | |
| HVTT and tumor | 1 | ||
| TT within the tumor boundary | 2 | 3 | |
| TT beyond the tumor boundary | 11 | 10 | |
| TT in IVC | 1 | ||
| No | 7 | 6 | |
| Yes | 6 | 7 | |
| Child-pugh grade | 0.16 | ||
| A | 12 | 8 | |
| B | 1 | 5 | |
| Age, year | 60, 31–73 | 58, 25–82 | 0.758 |
| ALT, U/L | 30.3, 15.5–278 | 55.8, 12.6–110.6 | 0.663 |
| TBil, μmol/L | 14.5, 9.6–37.5 | 22.1, 8.2–82.9 | 0.191 |
| ALB, g/L | 39.3, 28.9–45.3 | 36.8, 30.9–43.6 | 0.248 |
| ALP, U/L | 96.4, 69.8–459.7 | 88.8, 56–271.9 | 0.555 |
| PLT, ~103/μL | 141, 102–398 | 123, 30–301 | 0.209 |
| PTA, percent | 98%, 67%-1.07% | 85%, 54%-1.09% | 0.257 |
| AFP, μg/L | 60.6, 7.56–74506 | 1928, 2.4–37271 | 0.118 |
| CEA, μg/L | 2.4, 0.4–6.9 | 2.3, 0.8–10.7 | 0.951 |
| CA19-9, μg/L | 30.5, 11.1–100 | 24.2, 7.8–120.3 | 0.535 |
| Number of tumor | 2, 1–6 | 4, 1–10 | 0.372 |
| Diameter of tumor, mm | 49, 25–108 | 38, 15–120 | 0.837 |
| Length of TT, mm | 43, 27–85 | 31,16–90 | 0.4 |
Abbreviations: HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; HCV, hepatitis C virus; EHM, extrahepatic metastases; LNM, lymph node metastases; HVTT, hepatic vein tumor thrombus; HV, hepatic vein; TT, tumor thrombus; IVC, inferior vena cava; ALT, alanine aminotransferase; TBil, total bilirubin; ALB, albumin; ALP, alkaline phosphatase; PLT, platelet; PTA, prothrombin time activity; AFP, alpha-fetoprotein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19–9.